Behind the science
‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options
Living with incurable blood cancers often means navigating lifelong treatment, debilitating side effects, and frequent hospital visits. Now, scientists are working hard to find new solutions and give patients the quality of life they deserve.
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.















